# Nuclide record tc-99m-hmpao-brain (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/tc-99m-hmpao-brain/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "tc-99m-hmpao-brain" ;
  schema:name "Technetium-99m exametazime (brain perfusion)"@en ;
  schema:alternateName "Ceretec"@en, "Tc-99m HMPAO"@en, "HMPAO"@en, "Ceretec" ;
  schema:description "A cold-kit radioactive tracer that maps blood flow inside the brain on a SPECT scan, used mainly to look for the effects of stroke and, off-label in practice, to help support a diagnosis of brain death."@en ;
  schema:url <https://nuclide.cc/drugs/tc-99m-hmpao-brain/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019829s034lbl.pdf>, <https://snmmi.org/common/Uploaded%20files/Web/Education%20and%20Meetings/SNMMI%20Fact%20Sheet_Brain%20Death%20Fact%20Sheet%20Ceretec%20-Tc-99m%20HMPAO.pdf> ;
  nuclide:status "approved" ;
  nuclide:tag "SPECT", "diagnostic", "neurology", "perfusion imaging" ;
  nuclide:modality "SPECT tracer" ;
  nuclide:approval "US 1994: Cerebral scintigraphy as an adjunct in the detection of altered regional cerebral perfusion in stroke; and leukocyte-labelled scintigraphy for localising intra-abdominal infection and inflammatory bowel disease" ;
  nuclide:related <https://nuclide.cc/companies/ge-healthcare/>, <https://nuclide.cc/technologies/spect/>, <https://nuclide.cc/drugs/f-18-fdg-brain/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/tc-99m/> .